COVID-19 and Anti-Cancer Therapies

The severe acute respiratory syndrome CORONAVIRUS 2 (SARS-CoV-2) has caused a global pandemic, and cancer patients, along with the people who have a history of cancer, are in the high-risk category, different anti-cancer therapies that help reduce and prevent tumors through immunosuppression can have adverse effects with the COVID-19. If the function of T and B cells is impaired, the patient will not be able to mount an adequate immunity even after vaccination. However, some anti-cancer regimens can work with the system and against viral infection. This review focuses on the positive and negative effects of different anti-cancer therapies and how they affect COVID-19 vaccine efficacy.